1 – 10 of 45
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
High prevalence of FAP+ cancer-associated fibroblasts predicts poor outcome in patients with high-grade serous ovarian cancer with high CD8 T-cell density
Corvigno, Sara ; Fernebro, Josefin LU ; Karlsson, Josefin Severin ; Mezheieusky, Artur ; Martín-Bernabé, Alfonso ; De La Fuente, Laura Martin LU ; Westbom-Fremer, Sofia LU
; Carlson, Joseph W.
; Klein, Christian
and Kannisto, Paivi
LU
, et al.
(2025)
In Gynecologic Oncology
193.
p.148-155
- Contribution to journal › Article
-
Mark
Copy number signatures in cervical samples enable early detection of high-grade serous ovarian carcinoma
Veerla, Srinivas LU
; Martin de la Fuente, Laura
LU
; Li, Minerva
LU
; Tang, Guyuan
; Ebbesson, Anna
LU
; D'Incalci, Maurizio
; Marchini, Sergio
; Mannarino, Laura
; Måsbäck, Anna
LU
and Malander, Susanne
LU
, et al.
(2025)
SCRM 2025 - the 7th Swedish Cancer Research Meeting
- Contribution to conference › Poster
- 2024
-
Mark
Safe to save blood in ovarian cancer surgery : time to change transfusion habits
Norbeck, Anna LU ; Bengtsson, Jesper ; Malander, Susanne LU
; Asp, Mihaela
LU
and Kannisto, Päivi
LU
(2024)
In Acta Oncologica
63.
p.728-735
- Contribution to journal › Article
-
Mark
Tru-cut biopsy in gynecological cancer: adequacy, accuracy, safety and clinical applicability
Asp, Mihaela LU
; Mockute, Ingrida
LU
; Måsbäck, Anna
LU
; Liuba, Karina
LU
; Kannisto, Päivi
LU
and Malander, Susanne
LU
(2024)
34th World Congress on Ultrasound in Obstetrics and Gynecology
In Ultrasound in Obstetrics & Gynecology
64(S1).
p.65-65
- Contribution to journal › Published meeting abstract
-
Mark
Beyond HRD Status : Unraveling Genetic Variants Impacting PARP Inhibitor Sensitivity in Advanced Ovarian Cancer
Kjeldsen, Maj K. ; Jørgensen, Morten ; Grønseth, Dina Sofie B. ; Schønemann-Lund, Martin ; Nyvang, Gitte Bettina ; Haslund, Charlotte Aaquist ; Knudsen, Anja Oer ; Motavaf, Anne Krejbjerg ; Malander, Susanne LU
and Anttila, Maarit
, et al.
(2024)
In Cancer Research Communications
4(12).
p.3190-3200
- Contribution to journal › Article
- 2023
-
Mark
Age and Referral Route Impact the Access to Diagnosis for Women with Advanced Ovarian Cancer
Norbeck, Anna LU ; Asp, Mihaela LU
; Carlsson, Tobias
; Kannisto, Päivi
LU
and Malander, Susanne
LU
(2023)
In Journal of Multidisciplinary Healthcare
16.
p.1239-1248
- Contribution to journal › Article
-
Mark
Tru-Cut Biopsy in Gynecological Cancer: Adequacy, Accuracy, Safety and Clinical Applicability
Asp, Mihaela LU
; Mockute, Ingrida
LU
; Måsbäck, Anna
LU
; Liuba, Karina
LU
; Kannisto, Päivi
LU
and Malander, Susanne
LU
(2023)
In Journal of Multidisciplinary Healthcare
16.
p.1367-1377
- Contribution to journal › Article
- 2022
-
Mark
Copy number signatures for early diagnosis of high-grade serous ovarian carcinoma
Martin de la Fuente, Laura LU ; Li, Minerva LU ; Måsbäck, Anna LU ; Malander, Susanne LU
; Kannisto, Päivi
LU
and Hedenfalk, Ingrid
LU
(2022)
“FUTURE PERSPECTIVES IN OVARIAN CANCER RESEARCH”
- Contribution to conference › Poster
-
Mark
Ovarian tumor frozen section, a multidisciplinary affair
Asp, Mihaela LU
; Peber, Ebba
; Kannisto, Päivi
LU
; Måsbäck, Anna
LU
and Malander, Susanne
LU
(2022)
In Acta Oncologica
61(7).
p.785-792
- Contribution to journal › Article
-
Mark
The role of computed tomography in the assessment of tumour extent and the risk of residual disease after upfront surgery in advanced ovarian cancer (AOC)
Asp, Mihaela LU
; Malander, Susanne
LU
; Wallengren, Nils-Olof
LU
; Pudaric, Sonja
LU
; Bengtsson, Johan
LU
; Sartor, Hanna
LU
and Kannisto, Päivi
LU
(2022)
In Archives of Gynecology and Obstetrics
- Contribution to journal › Article